Because the epidermal growth factor receptor (EGFR) is highly expressed in nearly all carcinomas and capable of receptor recycling after endocytosis (61), we sought to determine whether an EGFR-targeting ligand could enable tumor-directed chimera delivery. The gene discussed is EGFR; the disease is carcinoma.